Kanker Payudara

Celestial Alignment: Navigating the Energetic Shifts of October 11–17, 2026

• Integrative Oncology and Holistic Care

Celestial Alignment: Navigating the Energetic Shifts of October 11–17, 2026

Ali Ikhwan October 11, 2026

Published: October 10, 2026 | 04:04 AM Analysis: The cosmic landscape of mid-October 2026 marks a pivotal...

Read More Read more about Celestial Alignment: Navigating the Energetic Shifts of October 11–17, 2026

From Resilience to Leadership: The Enduring Legacy of Richard Goldman and the Shanti Project

• Integrative Oncology and Holistic Care

From Resilience to Leadership: The Enduring Legacy of Richard Goldman and the Shanti Project

Nana October 11, 2026

Introduction: The Architecture of Compassion In the tapestry of the LGBTQ+ rights movement, the narratives of individual...

Read More Read more about From Resilience to Leadership: The Enduring Legacy of Richard Goldman and the Shanti Project

Advancing the Frontier of Oncology: Taylor & Francis Calls for Submissions on Biliary Cancer Innovation

• Clinical Oncology Education

Advancing the Frontier of Oncology: Taylor & Francis Calls for Submissions on Biliary Cancer Innovation

Ammar Sabilarrohman October 11, 2026

Introduction: The Urgent Need for Progress in Hepatobiliary Care Biliary tract cancers—a group of aggressive, rare, and...

Read More Read more about Advancing the Frontier of Oncology: Taylor & Francis Calls for Submissions on Biliary Cancer Innovation

Navigating the Post-Treatment Journey: Breast Cancer Canada Launches Essential Wellness Series

• Psychosocial Support and Mental Health

Navigating the Post-Treatment Journey: Breast Cancer Canada Launches Essential Wellness Series

Laily UPN October 11, 2026

The conclusion of active breast cancer treatment is often viewed by the medical community as a milestone...

Read More Read more about Navigating the Post-Treatment Journey: Breast Cancer Canada Launches Essential Wellness Series

Regulatory Shift: The End of Disparate Impact Enforcement Under Title VI

• Breast Cancer Legislation and Policy

Regulatory Shift: The End of Disparate Impact Enforcement Under Title VI

Nana Muazin October 11, 2026

Introduction: A Fundamental Change in Federal Civil Rights Oversight On July 23, 2026, the Department of Health...

Read More Read more about Regulatory Shift: The End of Disparate Impact Enforcement Under Title VI

The Intersection of GLP-1 Medications and Breast Cancer: Navigating the Emerging Science

• Survivorship and Post-Treatment

The Intersection of GLP-1 Medications and Breast Cancer: Navigating the Emerging Science

Laily UPN October 11, 2026

By Editorial Staff, based on insights from Douglas Feil, NBCF Chief Program Officer Medical Disclaimer: The information...

Read More Read more about The Intersection of GLP-1 Medications and Breast Cancer: Navigating the Emerging Science

A Natural Evolution: Autologous Fat Transfer as a New Frontier in Post-Mastectomy Breast Reconstruction

• Breast Cancer Surgery and Reconstruction

A Natural Evolution: Autologous Fat Transfer as a New Frontier in Post-Mastectomy Breast Reconstruction

Evan Lee Salim October 11, 2026

For decades, the standard path for women undergoing mastectomy has been a choice between two primary options:...

Read More Read more about A Natural Evolution: Autologous Fat Transfer as a New Frontier in Post-Mastectomy Breast Reconstruction

Biotech Market Pulse: FDA Regulatory Shifts, Strategic Capital, and Clinical Updates

• Chemotherapy and Targeted Therapy

Biotech Market Pulse: FDA Regulatory Shifts, Strategic Capital, and Clinical Updates

Lina Hope October 11, 2026

The biopharmaceutical landscape is undergoing a period of intense scrutiny and recalibration. This week’s developments—ranging from regulatory...

Read More Read more about Biotech Market Pulse: FDA Regulatory Shifts, Strategic Capital, and Clinical Updates

The Digital Pathology Revolution: Mining Legacy Data to Reshape Preclinical Research

• Chemotherapy and Targeted Therapy

The Digital Pathology Revolution: Mining Legacy Data to Reshape Preclinical Research

Neng Nana October 11, 2026

The landscape of drug discovery is undergoing a profound transformation. What was once a static, one-way process—where...

Read More Read more about The Digital Pathology Revolution: Mining Legacy Data to Reshape Preclinical Research

Illuminating the Shadows: The Global Effort to Defeat Metastatic Breast Cancer

• Metastatic Breast Cancer Research

Illuminating the Shadows: The Global Effort to Defeat Metastatic Breast Cancer

Reynand Wu October 11, 2026

NEW YORK, NY – As October marks Breast Cancer Awareness Month, the familiar landscape of pink ribbons...

Read More Read more about Illuminating the Shadows: The Global Effort to Defeat Metastatic Breast Cancer